The United Laboratories International Holdings Limited

SEHK:3933 Lagerbericht

Marktkapitalisierung: HK$18.1b

United Laboratories International Holdings Ausschüttungen und Rückkäufe

Zukünftiges Wachstum Kriterienprüfungen 3/6

United Laboratories International Holdings ist ein dividendenzahlendes Unternehmen mit einer aktuellen Rendite von 5.93%, die durch die Erträge gut gedeckt ist.

Wichtige Informationen

5.9%

Dividendenausschüttung

0.005%

Rückkaufsrendite

Gesamte Aktionärsrendite5.9%
Zukünftige Dividendenrendite3.3%
Wachstum der Dividende22.5%
Nächster Dividendenzahlungsterminn/a
Ex-Dividendendatumn/a
Dividende pro AktieHK$0.615
Ausschüttungsquote27%

Jüngste Updates zu Dividenden und Rückkäufen

Recent updates

These 4 Measures Indicate That United Laboratories International Holdings (HKG:3933) Is Using Debt Safely

Nov 11
These 4 Measures Indicate That United Laboratories International Holdings (HKG:3933) Is Using Debt Safely

The United Laboratories International Holdings Limited (HKG:3933) Stock Catapults 29% Though Its Price And Business Still Lag The Market

Oct 23
The United Laboratories International Holdings Limited (HKG:3933) Stock Catapults 29% Though Its Price And Business Still Lag The Market

Here's Why We Think United Laboratories International Holdings (HKG:3933) Is Well Worth Watching

Aug 30
Here's Why We Think United Laboratories International Holdings (HKG:3933) Is Well Worth Watching

Improved Earnings Required Before The United Laboratories International Holdings Limited (HKG:3933) Stock's 26% Jump Looks Justified

Feb 29
Improved Earnings Required Before The United Laboratories International Holdings Limited (HKG:3933) Stock's 26% Jump Looks Justified

The United Laboratories International Holdings Limited's (HKG:3933) Low P/E No Reason For Excitement

Jan 04
The United Laboratories International Holdings Limited's (HKG:3933) Low P/E No Reason For Excitement

United Laboratories International Holdings (HKG:3933) Could Easily Take On More Debt

Dec 14
United Laboratories International Holdings (HKG:3933) Could Easily Take On More Debt

With EPS Growth And More, United Laboratories International Holdings (HKG:3933) Makes An Interesting Case

Nov 26
With EPS Growth And More, United Laboratories International Holdings (HKG:3933) Makes An Interesting Case

Is United Laboratories International Holdings (HKG:3933) A Risky Investment?

Aug 31
Is United Laboratories International Holdings (HKG:3933) A Risky Investment?

Does United Laboratories International Holdings (HKG:3933) Deserve A Spot On Your Watchlist?

Aug 10
Does United Laboratories International Holdings (HKG:3933) Deserve A Spot On Your Watchlist?

United Laboratories International Holdings (HKG:3933) Has A Rock Solid Balance Sheet

Dec 23
United Laboratories International Holdings (HKG:3933) Has A Rock Solid Balance Sheet

Are Investors Undervaluing The United Laboratories International Holdings Limited (HKG:3933) By 47%?

Oct 19
Are Investors Undervaluing The United Laboratories International Holdings Limited (HKG:3933) By 47%?

Is United Laboratories International Holdings (HKG:3933) Using Too Much Debt?

Aug 30
Is United Laboratories International Holdings (HKG:3933) Using Too Much Debt?

Is The United Laboratories International Holdings Limited (HKG:3933) A Smart Pick For Income Investors?

Mar 08
Is The United Laboratories International Holdings Limited (HKG:3933) A Smart Pick For Income Investors?

The United Laboratories International Holdings (HKG:3933) Share Price Is Up 108% And Shareholders Are Boasting About It

Feb 18
The United Laboratories International Holdings (HKG:3933) Share Price Is Up 108% And Shareholders Are Boasting About It

The United Laboratories International Holdings Limited's (HKG:3933) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Feb 03
The United Laboratories International Holdings Limited's (HKG:3933) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Did The United Laboratories International Holdings Limited (HKG:3933) Insiders Sell Shares?

Jan 19
Did The United Laboratories International Holdings Limited (HKG:3933) Insiders Sell Shares?

We Wouldn't Rely On United Laboratories International Holdings's (HKG:3933) Statutory Earnings As A Guide

Jan 04
We Wouldn't Rely On United Laboratories International Holdings's (HKG:3933) Statutory Earnings As A Guide

These 4 Measures Indicate That United Laboratories International Holdings (HKG:3933) Is Using Debt Safely

Dec 20
These 4 Measures Indicate That United Laboratories International Holdings (HKG:3933) Is Using Debt Safely

What Type Of Shareholders Own The Most Number of The United Laboratories International Holdings Limited (HKG:3933) Shares?

Dec 07
What Type Of Shareholders Own The Most Number of The United Laboratories International Holdings Limited (HKG:3933) Shares?

The United Laboratories International Holdings Limited (HKG:3933) Is Yielding 1.3% - But Is It A Buy?

Nov 23
The United Laboratories International Holdings Limited (HKG:3933) Is Yielding 1.3% - But Is It A Buy?

Stabilität und Wachstum des Zahlungsverkehrs

Rufe Dividendendaten ab

Stabile Dividende: 3933 zahlt seit weniger als 10 Jahren eine Dividende, und während dieser Zeit waren die Zahlungen volatil.

Wachsende Dividende: 3933Die Dividendenzahlungen des Unternehmens sind gestiegen, aber das Unternehmen zahlt erst seit 7 Jahren eine Dividende.


Dividendenrendite im Vergleich zum Markt

United Laboratories International Holdings Dividendenrendite im Vergleich zum Markt
Wie sieht die Dividendenrendite von 3933 im Vergleich zum Markt aus?
SegmentDividendenrendite
Unternehmen (3933)5.9%
Untere 25 % des Marktes (HK)3.2%
Markt Top 25 % (HK)8.0%
Branchendurchschnitt (Pharmaceuticals)3.8%
Analystenprognose (3933) (bis zu 3 Jahre)3.3%

Bemerkenswerte Dividende: 3933Die Dividende des Unternehmens (5.93%) ist höher als die der untersten 25% der Dividendenzahler auf dem Hong Kong Markt (3.21%).

Hohe Dividende: 3933Die Dividende des Unternehmens (5.93%) ist im Vergleich zu den besten 25% der Dividendenzahler auf dem Markt Hong Kong (8.02%) niedrig.


Gewinnausschüttung an die Aktionäre

Abdeckung der Erträge: Mit einer relativ niedrigen Ausschüttungsquote (27.5%) sind die Dividendenzahlungen von 3933 gut durch die Erträge gedeckt.


Barausschüttung an die Aktionäre

Cashflow-Deckung: Mit einer angemessenen Ausschüttungsquote (70.9%) sind die Dividendenzahlungen von 3933 durch den Cashflow gedeckt.


Entdecken Sie dividendenstarke Unternehmen